The University of Chicago Header Logo

Connection

Richard Schilsky to Piperazines

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Piperazines.
Richard Schilsky
Connection Strength
0.046
Piperazines
  1. A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer. Cancer Med. 2022 07; 11(14):2790-2800.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.